Accelerating manufacturing to start large-scale supply of a new adenovirus-vectored vaccine within 100 days
C. C. Joe, R. R. Segireddy, C. Oliveira, A. Berg, Y. Li, D. Doultsinos, N. Chopra, S. Scholze, A. Ahmad, P. Nestola, J. Niemann, A. Douglas
This paper describes an accelerated manufacturing process for adenovirus-vectored vaccines, enabling large-scale supply within 100 days of pathogen identification.
bioRxiv · Dec 22, 2021 · PreprintBioengineering